
The editor in chief of Evidence-Based Oncology, who was recently named medical director of Precision Medicine for The US Oncology Network, discussed milestones met and those still to be achieved.
Because type 2 diabetes is associated with substantial burdens on health care resources in the United States, treatment approaches that minimize complications and reduce health care costs are needed.
Click PLAY to watch the video abstract.
Click
Click





